Pfizer CEO is “disappointed” with the performance of the mRNA vaccine (26-January-2022)

First published at 09:52 UTC on January 26th, 2022.

Former animal doctor: Instead of withdrawing a failing product from the market, Pfizer confirms it is doing more studies on “4th dose” and “higher doses” of that failing product.

CategoryEntertainment
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO